Ursprung des Netzwerks ersten Grades von Ryan Muldoon
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015.
4
| Private Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ryan Muldoon
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
HVIVO PLC | Miscellaneous Commercial Services | Founder | |
Babraham Bioscience Technologies Ltd.
Babraham Bioscience Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Babraham Bioscience Technologies Ltd. provides business research and consulting services. It also offers financial and administrative services to start-up biotech companies. The company was founded in 1996 and is located in Cambridge, UK | Miscellaneous Commercial Services | Director/Board Member | |
University of London | College/University | Doctorate Degree | |
University of Ulster | College/University | Masters Business Admin | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Founder | |
King's College London | College/University | Corporate Officer/Principal | |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Miscellaneous Commercial Services | Director/Board Member | |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Helperby Therapeutics Group Ltd.
Helperby Therapeutics Group Ltd. Miscellaneous Commercial ServicesCommercial Services Helperby Therapeutics Group Ltd. engages in the development of novel solutions to treat infectious diseases with new combinations of repurposed approved drugs. The company was founded by Anthony Milnes Coates in 2002 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Raglan Capital Ltd.
Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Investment Managers | Chief Executive Officer | |
Brabraham Biotechnology Ltd. | Director/Board Member | ||
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Oil & Gas Production | Director/Board Member | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Ananda Developments Plc
Ananda Developments Plc Investment ManagersFinance Ananda Developments Plc engages in the provision of cannabinoid medicines for the treatment of complex, chronic inflammatory pain conditions. The company was founded on January 19, 2018, and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member | |
Open Orphan DAC
Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | Packaged Software | Chief Executive Officer | |
HVIVO PLC | Miscellaneous Commercial Services | Founder | |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chairman | |
POOLBEG PHARMA PLC | Pharmaceuticals: Major | Founder |
Statistik
International
Vereinigtes Königreich | 18 |
Irland | 5 |
Australien | 2 |
Island | 2 |
Sektoral
Health Technology | 7 |
Commercial Services | 6 |
Finance | 5 |
Consumer Services | 4 |
Miscellaneous | 2 |
Operativ
Director/Board Member | 15 |
Founder | 12 |
Chairman | 11 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Clive Page | 13 |
Cathal Friel | 13 |
Bruce A. Malcolm | 1 |
Jim Cornelius | 1 |
- Börse
- Insiders
- Ryan Muldoon
- Unternehmensverbindungen